Interleukin-6 G-174C gene polymorphism and serum resistin levels in North Indian women: Potential risk of metabolic syndrome

Human and Experimental Toxicology

Volumn 30, Issue 10, 2011, Pages 1445-1453

  Gupta, A ^a   Gupta, V ^a   Singh, A K ^a   Tiwari, S ^a   Agrawal, S ^b   Natu, S M ^a   Agrawal, C G ^a   Negi, M P S ^c   Pant, A B ^d  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

abdominal obesity; interleukin 6 gene; metabolic risk factors; resistin

Indexed keywords

INSULIN; INTERLEUKIN 6; RESISTIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; INSULIN; INTERLEUKIN-6; LIPIDS; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; POLYMORPHISM, GENETIC; RESISTIN; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 80054872368     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110393763     Document Type: Article

References (39)

1. Godsland IF, Stevenson JC. Insulin resistance: syndrome or tendency? Review. Lancet. 1995 ; 346: 100-103
2. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006 ; 91: 2906-2912 (Pubitemid 44271734)
3. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000 ; 11: 327-332
4. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999 ; 38: 202-206
5. Steppan CM, Lazar MA. Resistin and obesity associated insulin resistance. Trends Endocrinol Metab. 2002 ; 13: 18-23 (Pubitemid 36734011)
6. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor α, in vivo. J Clin Endocrinol Metab. 1997 ; 82: 4196-4200 (Pubitemid 27525539)
7. Steppan CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001 ; 409: 307-312 (Pubitemid 32151228)
8. Nogueiras R, Bailey ST, Bhat S, et al. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 2003 ; 548: 21-27 (Pubitemid 37281244)
9. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet. 2002 ; 359: 46-47 (Pubitemid 34119198)
10. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004 ; 1: 161-168 (Pubitemid 40412718)
11. Ohmori R, Momiyama Y, Kato R, et al. Associations between serum resistin levels and insulin resistance, inflammation and coronary artery disease. J Am Coll Cardiol. 2005 ; 46: 379-380 (Pubitemid 40966873)
12. Rea R, Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?. Diabetes Obes Metab. 2004 ; 6: 163-170 (Pubitemid 38559695)
13. Way JM, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem. 2001 ; 276 (28). 25651-25653
14. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000 ; 148: 209-214 (Pubitemid 30064452)
15. Fernandez-Real JM, et al. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab. 2000 ; 85: 1334-1339
16. Vozarova B, et al. Circulating IL-6 in relation to adiposity, insulin action and insulin secretion. Obes Res. 2001 ; 9 (7). 414-417 (Pubitemid 33603868)
17. Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun. 2003 ; 17: 350-364 (Pubitemid 36999842)
18. Jansson JO, et al. On the site and mechanism of action of the anti-obesity effects of interleukin-6, Growth Horm. IGF Res. 2003 ; 13: 28-32
19. Fishman D, et al. The effect of novel polymorphisms in the interleukin-6 (IL6) gene on IL6 transcription and plasma IL6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998 ; 102 (7). 1369-1376 (Pubitemid 28467565)
20. Brull DJ, et al. Interleukin-6 gene -174G/C and -572G/C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001 ; 21 (9). 1458-1463 (Pubitemid 34219808)
21. Bokarewa M, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005 ; 174: 5789-5795 (Pubitemid 40593223)
22. Kalra A, Nair SK, Rai L. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci. 2006 ; 60 (11). 447-453 (Pubitemid 44729776)
23. Ascaso JF, et al. Insulin Resistance quantification by fasting insulin plasma values and HOMA Index in a non diabetic population. Med Clin. 2001 ; 117 (14). 530-533 (Pubitemid 33100193)
24. Schotte H, et al. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology. 2001 ; 40: 393-400
25. Third National Family Health Survey. Mumbai: International Institute for Population Sciences. 2006. http://nfhsindia.org/nfhs3-national-report.html.
26. Okuno A, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest. 1998 ; 101 (6). 1354-1361 (Pubitemid 28145252)
27. Dandona P, et al. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998 ; 83 (8). 2907-2910 (Pubitemid 28493796)
28. Herbert A, et al. BMI Modifies Associations of IL-6 Genotypes with Insulin Resistance: The Framingham Study. Obesity. 2006 ; 14 (8). 1454-1461 (Pubitemid 46219672)
29. Mattacks CA, Pond CM. Interactions of noradrenalin and tumor necrosis factor, interleukin-4 and interleukin-6 in the control of lipolysis from adipocytes around lymph nodes. Cytokine. 1999 ; 11 (5). 334-346 (Pubitemid 29233967)
30. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and TNF-α, overexpressed in human fat cells from insulin -resistant subjects. J Biol Chem. 2003 ; 278: 45777-45784 (Pubitemid 37432722)
31. Path G, et al. Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab. 2001 ; 86 (5). 2281-2288 (Pubitemid 32472953)
32. Wernstedt I, et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord. 2004 ; 28 (10). 1272-1279 (Pubitemid 39389584)
33. Coon CS New Encyclopedia Britannica (University of Chicago, USA). 2004: 839.
34. Bhanoori M, et al. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women. J Soc Gynecol Investig. 2004 ; 12 (5). 365-369
35. Janke J, et al. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002 ; 10 (1). 1-5 (Pubitemid 135686624)
36. Vendrell J, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004 ; 12 (6). 962-971
37. Degawa-Yamauchi M, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab. 2003 ; 88 (11). 5452-5455 (Pubitemid 37452753)
38. Valsamakis G, et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favourable changes in serum adipocytokines. Metab Clin Exp. 2004 ; 53 (4). 430-434 (Pubitemid 38419183)
39. Riikola A, et al. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis. 2009 ; 207 (2). 466-470